Abstract:The long pentraxin 3 (PTX3) is a soluble glycoprotein made by immune and nonimmune cells endowed with pleiotropic functions in innate immunity, inflammation, and tissue remodeling. PTX3 has recently emerged as a mediator of bone turnover in both physiological and pathological conditions, with direct and indirect effects on osteoblasts and osteoclasts. This notwithstanding, its role in bone biology, with major regard to the osteogenic potential of osteoblasts and their interplay with osteoclasts, is at present unclear. Here, we investigated the contribution of this pentraxin to bone deposition in the osteogenic lineage by assessing collagen production, mineralization capacity, osteoblast maturation, extracellular matrix gene expression, and inflammatory mediators' production in primary osteoblasts from the calvaria of wild-type (WT) and Ptx3-deficient (Ptx3-/-) mice. Also, we evaluated the effect of PTX3 on osteoclastogenesis in cocultures of primary osteoblasts and bone marrow-derived osteoclasts. Our investigations were carried out both in physiological and inflammatory conditions to recapitulate in vitro aspects of inflammatory diseases of the bone. We found that primary osteoblasts from WT animals constitutively expressed low levels of the protein in osteogenic noninflammatory conditions, and genetic ablation of PTX3 in these cells had no major impact on collagen and hydroxyapatite deposition. However, Ptx3-/- osteoblasts had an increased RANKL/OPG ratio and CD44 expression, which resulted in in enhanced osteoclastogenesis when cocultured with bone marrow monocytes. Inflammation (modelled through administration of tumor necrosis factor-α, TNF-α) boosted the expression and accumulation of PTX3 and inflammatory mediators in WT osteoblasts. In these conditions, Ptx3 genetic depletion was associated with reduced collagen deposition and immune modulators' production. Our study shed light on the role of PTX3 in osteoblast and osteoclast biology and identified a major effect of inflammation on the bone-related properties of this pentraxin, which might be relevant for therapeutic and/or diagnostic purposes in musculoskeletal pathology.

The Inducible Expression of the Long Pentraxin Ptx3 in Osteoblast-Like Mc 3T3-E1 Cells by E-Coli Lipopolysaccharide

PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells.

TRAF6/ERK/p38 Pathway is Involved in Interleukin-17-mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation.

Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions

PTX3 promotes osteogenic differentiation by triggering HA/CD44/FAK/AKT positive feedback loop in an inflammatory environment

PTX3 Protects Intestinal Mucosal Barrier Damage in Sepsis Through Toll-Like Receptor Signaling Pathway

The effects of LPS on the IL-6 expression in osteoblasts

Pathways Of Induction Of Peroxiredoxin I Expression In Osteoblasts - Roles Of P38 Mitogen-Activated Protein Kinase And Protein Kinase C

MAPK and NF-κB Up-Regulated the Expression of Toll-Like Receptor 4 Induced by LPS in Pulmonary Micro-Vascular Endothelial Cell in Mouse

Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells

Pentraxin 3 Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells Through JNK Signaling Pathway

The Molecular Mechanism of Lps-Induced Chi3l1 Expression

Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications

Stimulation of osteoclast differentiation by lipopolysaccharide

Cellular Study of the LPS-induced Osteoclastic Multinucleated Cell Formation from RAW264.7 Cells.

Pentraxin 3 deficiency ameliorates the severity of osteoarthritis and alleviates inflammation

Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells

Pentraxin 3 Activates JNK Signaling and Regulates the Epithelial-To-Mesenchymal Transition in Renal Fibrosis

Low-Intensity Pulsed Ultrasound Induced Osteoblast Differentiation Mediated by the PYK2-ERK2 Signaling in MC3T3-E1 Cells.

Lanthanum Enhances in Vitro Osteoblast Differentiation Via Pertussis Toxin-Sensitive Gi Protein and Erk Signaling Pathway

Pathways of Induction of Peroxiredoxin I Expression in Osteoblasts